STAT3 Pathway Targeting Type I Photosensitizer as an Immune Stimulator for Cancer Photoimmunotherapy
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c01062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Jingru Qiu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, School of Pharmaceutical S…. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Photosensitizing Agents, Immunotherapy, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Taishan Scholar Project of Shandong Province, Shandong University.
Abstract (Originalsprache)
Signal transducer and activator of transcription 3 (STAT3) is broadly hyperactivated in cancer cells and plays an important role in regulating cell proliferation and immunosuppression. Inhibiting STAT3 can enhance T cell-mediated antitumor immunity. Inducing immunogenic cell death (ICD) via danger-associated molecular pattern release facilitates the migration and infiltration of T cells into tumors, making ICD induction combined with STAT3 inhibition a promising synergistic cancer therapy. In this work, we discovered that an old cationic carbocyanine dye Stains-All (SA) was a STAT3 pathway targeting type I photosensitizer. SA triggered immunogenic apoptosis and pyroptosis of tumor cells and provoked antitumor immune responses. Meanwhile, SA prevented tumor growth and blocked immune escape by inhibiting STAT3 activation. Moreover, efficient ICD induction and STAT3 inhibition synergistically suppressed the growth of both primary and distant tumors. Overall, this study repurposed SA as a novel photoimmune stimulator targeting the STAT3 pathway for the synergistic tumor ablation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shan…
- Advanced Medical Research Institute, Meili Lake Translational Research Park, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, P. R. China.
ORCID-Profile: Donghai Li, Gang Shan
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Taishan Scholar Project of Shandong Province
- Shandong University
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Qiu, J., Liu, Q., Chen, B., Gao, Z., Zhang, S., Du, Y., Li, D., Li, G., & Shan, G. (2025). STAT3 Pathway Targeting Type I Photosensitizer as an Immune Stimulator for Cancer Photoimmunotherapy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c01062
Vancouver
Qiu J, Liu Q, Chen B, Gao Z, Zhang S, Du Y, et al. STAT3 Pathway Targeting Type I Photosensitizer as an Immune Stimulator for Cancer Photoimmunotherapy. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c01062
BibTeX
@article{Qiu2025,
author = {Qiu, Jingru and Liu, Qinghong and Chen, Baolan and Gao, Zhongfei and Zhang, Shuo and Du, Yayin and Li, Donghai and Li, Guiling and Shan, Gang},
title = {STAT3 Pathway Targeting Type I Photosensitizer as an Immune Stimulator for Cancer Photoimmunotherapy},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c01062}
}
EUVIMED